Evidence map›Paper›PMID 34353356›Full record

Observational studyAntimicrobial resistance and infection control2021

SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.

A Landoas, F Cazzorla, M Gallouche, S Larrat, B Nemoz, C Giner, M Le Maréchal, P Pavese, O Epaulard, P Morand and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Antimicrobial resistance and infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A new method for near real-time, nationwide surveillance of nosocomial COVID-19 in Norway: providing data at all levels of the healthcare system, March 2020 to March 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

A LandoasInfection Control Unit, Grenoble Alpes University Hospital, Grenoble, France.
F CazzorlaInfection Control Unit, Grenoble Alpes University Hospital, Grenoble, France.
M GalloucheInfection Control Unit, Grenoble Alpes University Hospital, Grenoble, France.
S LarratVirology Laboratory, Grenoble Alpes University Hospital, Grenoble, France.
B NemozVirology Laboratory, Grenoble Alpes University Hospital, Grenoble, France.
C GinerInfection Control Unit, Grenoble Alpes University Hospital, Grenoble, France.
M Le MaréchalInfectious Diseases Department, Grenoble Alpes University Hospital, Grenoble, France.
P PaveseInfectious Diseases Department, Grenoble Alpes University Hospital, Grenoble, France.
O EpaulardInfectious Diseases Department, Grenoble Alpes University Hospital, Grenoble, France.
P MorandVirology Laboratory, Grenoble Alpes University Hospital, Grenoble, France.
M-R MallaretInfection Control Unit, Grenoble Alpes University Hospital, Grenoble, France.
C LandelleInfection Control Unit, Grenoble Alpes University Hospital, Grenoble, France. caroline.landelle@gmail.com.ORCID 0000-0002-3592-1948

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn healthcare facilities, nosocomial transmissions of respiratory viruses are a major issue. SARS-CoV-2 is not exempt from nosocomial transmission. Our goals were to describe COVID-19 nosocomial cases during the first pandemic wave among patients in a French university hospital and compliance with hygiene measures.

methodsWe conducted a prospective observational study in Grenoble Alpes University Hospital from 01/03/2020 to 11/05/2020. We included all hospitalised patients with a documented SARS-CoV-2 diagnosis. Nosocomial case was defined by a delay of 5 days between hospitalisation and first symptoms. Hygiene measures were evaluated between 11/05/2020 and 22/05/2020. Lockdown measures were effective in France on 17/03/2020 and ended on 11/05/2020. Systematic wearing of mask was mandatory for all healthcare workers (HCW) and visits were prohibited in our institution from 13/03/2021 and for the duration of the lockdown period.

resultsAmong 259 patients included, 14 (5.4%) were considered as nosocomial COVID-19. Median time before symptom onset was 25 days (interquartile range: 12-42). Eleven patients (79%) had risk factors for severe COVID-19. Five died (36%) including 4 deaths attributable to COVID-19. Two clusters were identified. The first cluster had 5 cases including 3 nosocomial acquisitions and no tested HCWs were positive. The second cluster had 3 cases including 2 nosocomial cases and 4 HCWs were positive. Surgical mask wearing and hand hygiene compliance were adequate for 95% and 61% of HCWs, respectively.

conclusionsThe number of nosocomial COVID-19 cases in our hospital was low. Compliance regarding mask wearing, hand hygiene and lockdown measures drastically reduced transmission of the virus. Monitoring of nosocomial COVID-19 cases during the first wave enabled us to determine to what extent the hygiene measures taken were effective and patients protected. Trial registration Study ethics approval was obtained retrospectively on 30 September 2020 (CECIC Rhône-Alpes-Auvergne, Clermont-Ferrand, IRB 5891).

Indexed as

AgedAged, 80 and overCOVID-19COVID-19 TestingCross InfectionFemaleFranceHand HygieneHealth PersonnelHospitals, UniversityHumansInfection ControlMaleMasksMiddle AgedPandemicsCOVID-19Hand hygieneHealthcare-associated infectionMaskOutbreakSARS-CoV-2

Identifiers

PMID34353356
PMCPMC8339707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.